274 related articles for article (PubMed ID: 11416087)
1. Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic.
Roest RW; van der Meijden WI; van Dijk G; Groen J; Mulder PG; Verjans GM; Osterhaus AD
Int J Epidemiol; 2001 Jun; 30(3):580-8. PubMed ID: 11416087
[TBL] [Abstract][Full Text] [Related]
2. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic.
Austin H; Macaluso M; Nahmias A; Lee FK; Kelaghan J; Fleenor M; Hook EW
Sex Transm Dis; 1999 Jul; 26(6):329-34. PubMed ID: 10417020
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.
Da Rosa-Santos OL; Gonçalves Da Silva A; Pereira AC
Int J Dermatol; 1996 Nov; 35(11):794-6. PubMed ID: 8915732
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.
Woestenberg PJ; Tjhie JH; de Melker HE; van der Klis FR; van Bergen JE; van der Sande MA; van Benthem BH
BMC Infect Dis; 2016 Aug; 16():364. PubMed ID: 27484304
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 2 seroepidemiology in Spain: prevalence and seroconversion rate among sexually transmitted disease clinic attendees.
Varela JA; García-Corbeira P; Agüanell MV; Boceta R; Ballesteros J; Aguilar L; Vázquez-Valdés F; Dal-ré R
Sex Transm Dis; 2001 Jan; 28(1):47-50. PubMed ID: 11196047
[TBL] [Abstract][Full Text] [Related]
6. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
Jonsson MK; Levi M; Rudén U; Wahren B
Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of herpes simplex virus-1 and -2 in attendees of a sexually transmitted infection clinic in Singapore.
Theng CT; Sen PR; Chio TW; Tan HH; Wong ML; Chan RK
Sex Health; 2006 Dec; 3(4):269-74. PubMed ID: 17112439
[TBL] [Abstract][Full Text] [Related]
8. Seropositivity and determinants of immunoglobulin-G (IgG) antibodies against Herpes simplex virus (HSV) types -1 and -2 in pregnant women in Port Harcourt, Nigeria.
Okonko IO; Cookey TI
Afr Health Sci; 2015 Sep; 15(3):737-47. PubMed ID: 26957960
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy.
Suligoi B; Calistri A; Cusini M; Palù G;
J Med Virol; 2002 Jul; 67(3):345-8. PubMed ID: 12116025
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial.
Gorfinkel IS; Aoki F; McNeil S; Dionne M; Shafran SD; Zickler P; Halperin S; Langley J; Bellamy A; Schulte J; Heineman T; Belshe R
Int J STD AIDS; 2013 May; 24(5):345-9. PubMed ID: 23970700
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors.
van de Laar MJ; Termorshuizen F; Slomka MJ; van Doornum GJ; Ossewaarde JM; Brown DW; Coutinho RA; van den Hoek JA
Int J Epidemiol; 1998 Feb; 27(1):127-34. PubMed ID: 9563706
[TBL] [Abstract][Full Text] [Related]
12. Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics.
Whittington WL; Celum CL; Cent A; Ashley RL
Sex Transm Dis; 2001 Feb; 28(2):99-104. PubMed ID: 11234793
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany.
Rabenau HF; Buxbaum S; Preiser W; Weber B; Doerr HW
Med Microbiol Immunol; 2002 Mar; 190(4):153-60. PubMed ID: 12005327
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of antibodies to herpes simplex virus types 1 and 2 among two sexually active female populations in Middlesbrough, England.
Opaneye AA; Bashford J
J R Soc Promot Health; 2002 Jun; 122(2):108-11. PubMed ID: 12134761
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of antibodies to herpes simplex virus type 2 among middle-aged women in Mexico City, Mexico: a population-based study.
Lazcano-Ponce E; Smith JS; Muñoz N; Conde-Glez CJ; Juárez-Figueroa L; Cruz A; Hernández M
Sex Transm Dis; 2001 May; 28(5):270-6. PubMed ID: 11354265
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil.
Carvalho M; de Carvalho S; Pannuti CS; Sumita LM; de Souza VA
Int J Infect Dis; 1998-1999 Winter; 3(2):94-8. PubMed ID: 10225987
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in Arkhangelsk, Northwest Russia: a population-based cross-sectional study.
Balaeva T; Grjibovski AM; Sidorenkov O; Samodova O; Firsova N; Sannikov A; Klouman E
BMC Infect Dis; 2016 Oct; 16(1):616. PubMed ID: 27793121
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy. Italian Herpes Forum.
Cusini M; Cusan M; Parolin C; Scioccati L; Decleva I; Mengoli C; Suligoi B; Palú G
Sex Transm Dis; 2000 May; 27(5):292-5. PubMed ID: 10821604
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes.
Wutzler P; Doerr HW; Färber I; Eichhorn U; Helbig B; Sauerbrei A; Brandstädt A; Rabenau HF
J Med Virol; 2000 Jun; 61(2):201-7. PubMed ID: 10797375
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalences of herpes simplex virus type 1 and type 2 among pregnant women in the Netherlands.
Gaytant MA; Steegers EA; van Laere M; Semmekrot BA; Groen J; Weel JF; van der Meijden WI; Boer K; Galama JM
Sex Transm Dis; 2002 Nov; 29(11):710-4. PubMed ID: 12438909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
